Abstract
Cardiovascular diseases top the list of fatal illnesses worldwide. Cardiac tissues is known to be one of te least proliferative in the human body, with very limited regenraive capacity. Stem cell therapy has shown great potential for treatment of cardiovascular diseases in the experimental setting, but success in human trials has been limited. Applications of stem cell therapy for cardiovascular regeneration necessitate understamding of the complex and unique structure of the heart unit, and the embryologic development of the heart muscles and vessels. This chapter aims to provide an insight into cardiac progenitor cells and their potential applications in regenerative medicine. It also provides an overview of the embryological development of cardiac tissue, and the major findings on the development of cardiac stem cells, their characterization, and differentiation, and their regenerative potential. It concludes with clinical applications in treating cardiac disease using different approaches, and concludes with areas for future research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Achilleos A, Trainor PA (2012) Neural crest stem cells: discovery, properties and potential for therapy. Cell Res 22(2):288–304
Aguilar-Sanchez C, Michael M, Pennings S (2018) Cardiac Stem Cells in the Postnatal Heart: Lessons from Development. Stem Cells Int 2018:1247857
Andrade D, Oliveira G, Menezes L, Nascimento AL, Carvalho S, Stumbo AC et al (2020) Insulin-like growth factor-1 short-period therapy improves cardiomyopathy stimulating cardiac progenitor cells survival in obese mice. Nutr Metab Cardiovasc Dis 30(1):151–161
Anversa P, Nadal-Ginard B (2002) Myocyte renewal and ventricular remodelling. Nature 415(6868):240–243
Aybar MJ, Mayor R (2002) Early induction of neural crest cells: lessons learned from frog, fish and chick. Curr Opin Genet Dev 12(4):452–458
Barile L, Gherghiceanu M, Popescu LM, Moccetti T, Vassalli G (2013) Human cardiospheres as a source of multipotent stem and progenitor cells. Stem Cells Int 2013:916837
Belostotskaya GB, Nerubatskaya IV, Galagudza MM (2018) Two mechanisms of cardiac stem cell-mediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cell-in-cell structures. Oncotarget 9(75):34159–34175
Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al (2003a) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6):763–776
Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al (2003b) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6):763–776
Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324(5923):98–102
Bergwerff M, Verberne ME, DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC (1998) Neural crest cell contribution to the developing circulatory system: implications for vascular morphology? Circ Res 82(2):221–231
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B et al (2010a) A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120(4):1125–1139
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B et al (2010b) A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120(4):1125–1139
Bohnen MS, Peng G, Robey SH, Terrenoire C, Iyer V, Sampson KJ et al (2017) Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev 97(1):89–134
Bondue A, Blanpain C (2010) Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 107(12):1414–1427
Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M et al (2008) Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3(1):69–84
Brade T, Pane LS, Moretti A, Chien KR, Laugwitz KL (2013) Embryonic heart progenitors and cardiogenesis. Cold Spring Harb Perspect Med 3(10):a013847
Buckingham M, Meilhac S, Zaffran S (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6(11):826–835
Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J et al (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5(6):877–889
Caplan AI (2017) Mesenchymal stem cells: time to change the name! Stem Cells Transl Med 6(6):1445–1451
Carpenter L, Carr C, Yang CT, Stuckey DJ, Clarke K, Watt SM (2012) Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev 21(6):977–986
Chai S, Wan X, Ramirez-Navarro A, Tesar PJ, Kaufman ES, Ficker E et al (2018) Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity. J Clin Invest 128(3):1043–1056
Cheitlin M. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. In: Menasché P, Alfieri O, Janssens S, et al (Université Paris Descartes, France; Ospedale San Raffaele, Milano, Italy; UZ Gasthuisberg, Leuven, Belgium; et al) Circulation 117: 1189-1200, 2008. Year book of cardiology. 2009;2009:413–415.
Chen L, Ashraf M, Wang Y, Zhou M, Zhang J, Qin G et al (2012) The role of notch 1 activation in cardiosphere derived cell differentiation. Stem Cells Dev 21(12):2122–2129
Chen Z, Xu J, Ye Y, Li Y, Gong H, Zhang G et al (2014) Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling. J Cell Mol Med 18(5):852–862
Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A et al (2010) Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106(5):971–980
Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I et al (2011) Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9(6):527–540
Chong JJ, Reinecke H, Iwata M, Torok-Storb B, Stempien-Otero A, Murry CE (2013) Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev 22(13):1932–1943
Christoffels VM, Mommersteeg MT, Trowe MO, Prall OW, de Gier-de Vries C, Soufan AT et al (2006) Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circ Res 98(12):1555–1563
Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD et al (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci 103(21):8155–8160
Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K et al (2009) Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 4(9):e7195
Dettman RW, Denetclaw W Jr, Ordahl CP, Bristow J (1998) Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 193(2):169–181
Devalla HD, Passier R (2018) Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease. Sci Transl Med 10(435):eaah5457
Dodou E, Verzi MP, Anderson JP, Xu SM, Black BL (2004) Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131(16):3931–3942
Doyle MJ, Lohr JL, Chapman CS, Koyano-Nakagawa N, Garry MG, Garry DJ (2015) Human induced pluripotent stem cell-derived cardiomyocytes as a model for heart development and congenital heart disease. Stem Cell Rev Rep 11(5):710–727
Durrani S, Konoplyannikov M, Ashraf M, Haider KH (2010) Skeletal myoblasts for cardiac repair. Regen Med 5(6):919–932
Dyer LA, Kirby ML (2009) The role of secondary heart field in cardiac development. Dev Biol 336(2):137–144
Fathi E, Valipour B, Vietor I, Farahzadi R (2020) An overview of the myocardial regeneration potential of cardiac c-Kit(+) progenitor cells via PI3K and MAPK signaling pathways. Futur Cardiol 16(3):199–209
Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK et al (2011) Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep 7(1):1–16
Forouhar AS, Liebling M, Hickerson A, Nasiraei-Moghaddam A, Tsai HJ, Hove JR et al (2006) The embryonic vertebrate heart tube is a dynamic suction pump. Science 312(5774):751–753
Galvez BG, Sampaolesi M, Barbuti A, Crespi A, Covarello D, Brunelli S et al (2008) Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ 15(9):1417–1428
Gao LR, Chen Y, Zhang NK, Yang XL, Liu HL, Wang ZG et al (2015) Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med 13:162
Garcia-Martinez V, Schoenwolf GC (1993) Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol 159(2):706–719
Garry DJ, Olson EN (2006) A common progenitor at the heart of development. Cell 127(6):1101–1104
Gavira JJ, Nasarre E, Abizanda G, Pérez-Ilzarbe M, de Martino-Rodriguez A, GarcÃa de Jalón JA et al (2010) Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. Eur Heart J 31(8):1013–1021
Genead R, Danielsson C, Andersson AB, Corbascio M, Franco-Cereceda A, Sylven C et al (2010) Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev 19(10):1601–1615
Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG, Poelmann RE (1998) Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 82(10):1043–1052
Golebiewska A, Brons NH, Bjerkvig R, Niclou SP (2011) Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 8(2):136–147
Goumans M-J, de Boer TP, Smits AM, van Laake LW, van Vliet P, Metz CH et al (2008) TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 1(2):138–149
Gurjarpadhye A, Hewett KW, Justus C, Wen X, Stadt H, Kirby ML et al (2007) Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles. Am J Physiol Heart Circ Physiol 292(3):H1291–H1300
Gwizdala A, Rozwadowska N, Kolanowski TJ, Malcher A, Cieplucha A, Perek B et al (2017) Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure. Eur J Heart Fail 19(1):148–157
Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP et al (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54(24):2277–2286
Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD et al (2007) Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13(8):970–974
Ishii Y, Langberg J, Rosborough K, Mikawa T (2009) Endothelial cell lineages of the heart. Cell Tissue Res 335(1):67–73
Jebeniani I, Ding S, Puceat M (1994) Improved Protocol for Cardiac Differentiation and Maturation of Pluripotent Stem Cells. Methods Mol Biol 2019:71–77
Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C et al (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96(1):127–137
Kannappan R, Matsuda A, Ferreira-Martins J, Zhang E, Palano G, Czarna A et al (2017) p53 modulates the fate of cardiac progenitor cells ex vivo and in the diabetic heart in vivo. EBioMedicine 16:224–237
Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T et al (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126(11_Suppl_1):S29–S37
Keyte A, Hutson MR (2012) The neural crest in cardiac congenital anomalies. Differentiation 84(1):25–40
Kirby ML, Gale TF, Stewart DE (1983) Neural crest cells contribute to normal aorticopulmonary septation. Science 220(4601):1059–1061
Kruithof BP, van Wijk B, Somi S, Kruithof-de Julio M, Perez Pomares JM, Weesie F et al (2006) BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 295(2):507–522
Kuhn EN, Wu SM (2010) Origin of cardiac progenitor cells in the developing and postnatal heart. J Cell Physiol 225(2):321–325
Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473(7347):326–335
Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026):647–653
Laugwitz KL, Moretti A, Caron L, Nakano A, Chien KR (2008) Islet1 cardiovascular progenitors: a single source for heart lineages? Development 135(2):193–205
Lavine KJ, Ornitz DM (2008) Fibroblast growth factors and Hedgehogs: at the heart of the epicardial signaling center. Trends Genet 24(1):33–40
Le T, Chong J (2016a) Cardiac progenitor cells for heart repair. Cell Death Dis 2:16052
Le T, Chong J (2016b) Cardiac progenitor cells for heart repair. Cell Death Dis 2:16052
Liao R, Pfister O, Jain M, Mouquet F (2007) The bone marrow--cardiac axis of myocardial regeneration. Prog Cardiovasc Dis 50(1):18–30
Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M et al (2008) Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 3(1):55–68
Liu N, Olson EN (2010) MicroRNA regulatory networks in cardiovascular development. Dev Cell 18(4):510–525
Madigan M, Atoui R (2018) Therapeutic use of stem cells for myocardial infarction. Bioengineering (Basel) 5(2)
Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S et al (2016) Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J 37(23):1789–1798
Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379(9819):895–904
Malliaras K, Li TS, Luthringer D, Terrovitis J, Cheng K, Chakravarty T et al (2012) Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125(1):100–112
Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS et al (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9(9):1195–1201
Männer J, Perez-Pomares J, Macias D, Munoz-Chapuli R (2001) The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs 169(2):89–103
Manner J, Perez-Pomares JM, Macias D, Munoz-Chapuli R (2001) The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs 169(2):89–103
Mansour S, Roy D-C, Bouchard V, Stevens LM, Gobeil F, Rivard A et al (2011) One-year safety analysis of the COMPARE-AMI trial: comparison of intracoronary injection of CD133. Bone Marrow Res 2011
Maring JA, Lodder K, Mol E, Verhage V, Wiesmeijer KC, Dingenouts CK et al (2019) Cardiac progenitor cell–derived extracellular vesicles reduce infarct size and associate with increased cardiovascular cell proliferation. J Cardiovasc Transl Res 12(1):5–17
Marvin MJ, Di Rocco G, Gardiner A, Bush SM, Lassar AB (2001) Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 15(3):316–327
Mathiasen AB, Qayyum AA, Jørgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF et al (2015) Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 36(27):1744–1753
Mauretti A, Spaans S, Bax NA, Sahlgren C, Bouten CV (2017) Cardiac progenitor cells and the interplay with their microenvironment. Stem Cells Int 2017
Mauritz C, Martens A, Rojas SV, Schnick T, Rathert C, Schecker N et al (2011) Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 32(21):2634–2641
Mazhari R, Hare JM (2007) Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4(1):S21–SS6
Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Myoblast transplantation for heart failure. Lancet 357(9252):279–280
Menasche P, Hagege A, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss 94(3):180–182
Mercola M, Ruiz-Lozano P, Schneider MD (2011) Cardiac muscle regeneration: lessons from development. Genes Dev 25(4):299–309
Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95(9):911–921
Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S et al (2012) A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine-and xeno-free conditions. Cell Rep 2(5):1448–1460
Mishra R, Vijayan K, Colletti EJ, Harrington DA, Matthiesen TS, Simpson D et al (2011) Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 123(4):364–373
Molkentin JD, Lin Q, Duncan SA, Olson EN (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11(8):1061–1072
Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y et al (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127(6):1151–1165
Müller P, Lemcke H, David R (2018) Stem cell therapy in heart diseases – cell types, mechanisms and improvement strategies. Cell Physiol Biochem 48(6):2607–2655
Naito AT, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A et al (2006) Developmental stage-specific biphasic roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci 103(52):19812–19817
Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10):3499–3506
Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A et al (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14(6):840–850
Noseda M, Peterkin T, Simoes FC, Patient R, Schneider MD (2011) Cardiopoietic factors: extracellular signals for cardiac lineage commitment. Circ Res 108(1):129–152
Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y et al (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100(21):12313–12318
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410(6829):701
Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T et al (2004) Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardio-thoracic Surg 25(4):627–634
Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwanaga K et al (2007) Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176(3):329–341
Pahnke A, Conant G, Huyer LD, Zhao Y, Feric N, Radisic M (2016) The role of Wnt regulation in heart development, cardiac repair and disease: A tissue engineering perspective. Biochem Biophys Res Commun 473(3):698–703
Park S-J, Kim RY, Park B-W, Lee S, Choi SW, Park J-H et al (2019) Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nat Commun 10(1):3123
Perez-Pomares JM, de la Pompa JL (2011) Signaling during epicardium and coronary vessel development. Circ Res 109(12):1429–1442
Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, Atencia G, Wessels A, Munoz-Chapuli R (2002) Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. Int J Dev Biol 46(8):1005–1013
Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A et al (2005) CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97(1):52–61
Phillips MT, Kirby ML, Forbes G (1987) Analysis of cranial neural crest distribution in the developing heart using quail-chick chimeras. Circ Res 60(1):27–30
Ptaszek LM, Mansour M, Ruskin JN, Chien KR (2012) Towards regenerative therapy for cardiac disease. Lancet 379(9819):933–942
Qayyum AA, Mathiasen AB, Helqvist S, Jorgensen E, Haack-Sorensen M, Ekblond A et al (2019) Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results. J Transl Med 17(1):360
Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L et al (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485(7400):593–598
Rahbarghazi R, Nassiri SM, Ahmadi SH, Mohammadi E, Rabbani S, Araghi A et al (2014) Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction. Int J Cardiol 173(3):453–466
Reifers F, Walsh EC, Leger S, Stainier DY, Brand M (2000) Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development 127(2):225–235
Reinecke H, Poppa V, Murry CE (2002) Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34(2):241–249
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707–1710
Rochais F, Mesbah K, Kelly RG (2009) Signaling pathways controlling second heart field development. Circ Res 104(8):933–942
Romagnuolo R, Masoudpour H, Porta-Sanchez A, Qiang B, Barry J, Laskary A et al (2019) Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Rep 12(5):967–981
Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G et al (2007) Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104(45):17783–17788
Roura S, Galvez-Monton C, Mirabel C, Vives J, Bayes-Genis A (2017) Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? Stem Cell Res Ther 8(1):238
Saga Y, Kitajima S, Miyagawa-Tomita S (2000) Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 10(8):345–352
Sahara M, Santoro F, Sohlmer J, Zhou C, Witman N, Leung CY et al (2019) Population and Single-Cell Analysis of Human Cardiogenesis Reveals Unique LGR5 Ventricular Progenitors in Embryonic Outflow Tract. Dev Cell 48(4):475–490. e7
Sanganalmath SK, Bolli R (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113(6):810–834
Sato A, Scholl AM, Kuhn EN, Stadt HA, Decker JR, Pegram K et al (2011) FGF8 signaling is chemotactic for cardiac neural crest cells. Dev Biol 354(1):18–30
Sauka-Spengler T, Bronner-Fraser M (2008) A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 9(7):557–568
Sawa Y, Yoshikawa Y, Toda K, Fukushima S, Yamazaki K, Ono M et al (2015) Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J 79(5):991–999
Schultheiss TM, Burch JB, Lassar AB (1997) A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11(4):451–462
Sebastião MJ, Serra M, Pereira R, Palacios I, Gomes-Alves P, Alves PM (2019) Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model. Stem Cell Res Ther 10(1):77
Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M et al (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493(7432):433
Sharma A, Zhang Y, Buikema JW, Serpooshan V, Chirikian O, Kosaric N et al (2018) Stage-specific effects of bioactive lipids on human iPSC cardiac differentiation and cardiomyocyte proliferation. Sci Rep 8(1):6618
Shenje LT, Field LJ, Pritchard CA, Guerin CJ, Rubart M, Soonpaa MH et al (2008) Lineage tracing of cardiac explant derived cells. PLoS One 3(4):e1929
Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR et al (2007) Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445(7124):177–182
Smits AM, van Laake LW, den Ouden K, Schreurs C, Szuhai K, van Echteld CJ et al (2009a) Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 83(3):527–535
Smits AM, Van Vliet P, Metz CH, Korfage T, Sluijter JP, Doevendans PA et al (2009b) Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4(2):232
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Takamiya M, Haider KH, Ashraf M (2011) Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS One 6(9):e25265
Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46(7):1339–1350
Tani-Matsuhana S, Vieceli FM, Gandhi S, Inoue K, Bronner ME (2018) Transcriptome profiling of the cardiac neural crest reveals a critical role for MafB. Dev Biol 444(Suppl 1):S209–SS18
Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S et al (2015) Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thoracic Cardiovasc Surg 150(5):1198–1208. e2
Tendera M, Wojakowski W, Rużyłło W, Chojnowska L, Kępka C, Tracz W et al (2009) Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) trial. Eur Heart J 30(11):1313–1321
Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA et al (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6(3):206–214
Tomita Y, Matsumura K, Wakamatsu Y, Matsuzaki Y, Shibuya I, Kawaguchi H et al (2005) Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 170(7):1135–1146
Tompkins BA, Balkan W, Winkler J, Gyöngyösi M, Goliasch G, Fernández-Avilés F et al (2018) Preclinical studies of stem cell therapy for heart disease. Circ Res 122(7):1006–1020
Torán JL, Aguilar S, López JA, Torroja C, Quintana JA, Santiago C et al (2017) CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome. Sci Rep 7(1):12490
Toyofuku T, Yoshida J, Sugimoto T, Yamamoto M, Makino N, Takamatsu H et al (2008) Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells. Dev Biol 321(1):251–262
Trembley MA, Velasquez LS, de Mesy Bentley KL, Small EM (2015) Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels. Development 142(1):21–30
Uchida S, De Gaspari P, Kostin S, Jenniches K, Kilic A, Izumiya Y et al (2013) Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Rep 1(5):397–410
Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L et al (2007) Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci 104(23):9685–9690
Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells – current trends and future prospective. Biosci Rep 35(2)
Unno K, Jain M, Liao R (2012) Cardiac side population cells: moving toward the center stage in cardiac regeneration. Circ Res 110(10):1355–1363
Valiente-Alandi I, Albo-Castellanos C, Herrero D, Sanchez I, Bernad A (2016) Bmi1+ cardiac progenitor cells contribute to myocardial repair following acute injury. Stem Cell Res Ther 7(1):100
Van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin S-CJ et al (2014) C-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509(7500):337
Walravens AS, Vanhaverbeke M, Ottaviani L, Gillijns H, Trenson S, Driessche NV et al (2018) Molecular signature of progenitor cells isolated from young and adult human hearts. Sci Rep 8(1):9266
Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH et al (2006) The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24(7):1779–1788
Wang WE, Chen X, Houser SR, Zeng C (2013) Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci 125(7):319–327
Willert K, Nusse R (2012) Wnt proteins. Cold Spring Harb Perspect Biol 4(9):a007864
Williams B (2001) Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 87(8):10–17
Winter EM, Grauss RW, Hogers B, van Tuyn J, van der Geest R, Lie-Venema H et al (2007) Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation 116(8):917–927
Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM et al (2006) Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127(6):1137–1150
Wu SM, Chien KR, Mummery C (2008) Origins and fates of cardiovascular progenitor cells. Cell 132(4):537–543
Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J et al (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A 110(34):13839–13844
Xing Y, Lv A, Wang L, Yan X (2012) The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem 360(1-2):279–287
Xu X, Francis R, Wei CJ, Linask KL, Lo CW (2006) Connexin 43-mediated modulation of polarized cell movement and the directional migration of cardiac neural crest cells. Development 133(18):3629–3639
Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93(1):23–67
Youn YH, Feng J, Tessarollo L, Ito K, Sieber-Blum M (2003) Neural crest stem cell and cardiac endothelium defects in the TrkC null mouse. Mol Cell Neurosci 24(1):160–170
Zhang J, Tian X, Peng C, Yan C, Li Y, Sun M et al (2018) Transplantation of CREG modified embryonic stem cells improves cardiac function after myocardial infarction in mice. Biochem Biophys Res Commun 503(2):482–489
Zhao JJ, Liu XC, Kong F, Qi TG, Cheng GH, Wang J et al (2014) Bone marrow mesenchymal stem cells improve myocardial function in a swine model of acute myocardial infarction. Mol Med Rep 10(3):1448–1454
Zhou B, von Gise A, Ma Q, Rivera-Feliciano J, Pu WT (2008a) Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem Biophys Res Commun 375(3):450–453
Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J et al (2008b) Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454(7200):109–113
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shouman, S. et al. (2020). Cardiac Progenitor Cells. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 11. Advances in Experimental Medicine and Biology(), vol 1312. Springer, Cham. https://doi.org/10.1007/5584_2020_594
Download citation
DOI: https://doi.org/10.1007/5584_2020_594
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71924-1
Online ISBN: 978-3-030-71925-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)